APA

Matthews D. R., Dejager S., Ahren B., Fonseca V., Ferrannini E., Couturier A., Foley J. E. & Zinman B. (20110316). Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. : Diabetes, obesity & metabolism.

Chicago

Matthews D R, Dejager S, Ahren B, Fonseca V, Ferrannini E, Couturier A, Foley J E and Zinman B. 20110316. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. : Diabetes, obesity & metabolism.

Harvard

Matthews D. R., Dejager S., Ahren B., Fonseca V., Ferrannini E., Couturier A., Foley J. E. and Zinman B. (20110316). Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. : Diabetes, obesity & metabolism.

MLA

Matthews D R, Dejager S, Ahren B, Fonseca V, Ferrannini E, Couturier A, Foley J E and Zinman B. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. : Diabetes, obesity & metabolism. 20110316.